Variation in echocardiography machines and probes are not well described in the perioperative period. We aimed to compare the estimation of severity of aortic stenosis with transthoracic echocardiography (TTE) using two semi-portable ultrasound machines. Experienced cardiac anaesthetists performed a limited transthoracic echocardiogram with two different semiportable ultrasound machines in patients with known aortic stenosis. The peak aortic jet velocity with continuous-wave Doppler and the time taken to obtain an acceptable envelope were recorded. The Sonosite M Turbo often underestimated the peak jet velocities (median jet velocity [IQR] 2.25 m/s [1.95 to 3.4] versus 3.85 m/s [3 to 4.2]; P <0.001) and required more time to get a satisfactory envelope than the GE Vivid I. There was no statistically or clinically significant difference between the velocities obtained from the Vivid I and those measured on the patient's formal cardiology preoperative transthoracic echocardiogram (median [IQR]: 3.95 m/s [3.0 to 4.7]; P=0.3). However, the velocities obtained by the M Turbo were significantly lower than those obtained by the formal preoperative transthoracic echocardiogram (P <0.001). With the expansion of transthoracic echocardiography amongst anaesthetists, underestimation of the peak aortic jet velocity can significantly underestimate the severity of aortic stenosis with potentially lethal clinical consequences. Semi-portable ultrasound machines with echocardiographic capability are not necessarily equivalent and can result in underestimation of severity of aortic stenosis.
The use of transthoracic echocardiography (TTE) in the perioperative period by anaesthetists is now well described 1,2 . TTE allows real-time evaluation of cardiac structure and function, diagnosis of the undifferentiated murmur, evaluation of hypotension and assessment of response to therapy. Most departments of anaesthesia now have multipurpose portable ultrasound machines with capability for TTE, in addition to nerve blockade and vascular cannulation.
There is preliminary data suggesting that Doppler functions on these machines compare reasonably well with standard echocardiography platforms, albeit with some issues with continuous-wave Doppler (CWD) and estimation of right ventricular systolic pressure 3 . Other researchers have found that CWD measurements of aortic valve velocity correlated well with low velocities less than 2 m/s, but significantly underestimated higher velocities over 2 m/s 4 . This has implications for estimating the severity of aortic stenosis (AS), which is fundamental in perioperative practice.
Stenotic valvular disease is associated with a significantly increased risk of adverse cardiac events in patients having non-cardiac surgery 5, 6 . Recent series suggest that anaesthe-sia technique, invasive monitoring and risk stratification are altered in patients with known AS 1, 7 .
Severity of aortic stenosis is quantified by multiple criteria, including peak jet velocity, pressure gradient and valve area. Peak jet velocity is well validated, a strong predictor of clinical outcome and easy to measure in a focused TTE 8 . Its use is emphasised in the recent American Heart Association guidelines, with a peak aortic jet velocity of 4 m/s or higher being a key feature of the definition and diagnosis of severe AS 9 .
Our tertiary referral anaesthesia department has a variety of ultrasound machines from different manufacturers. Two types of new machines were purchased with TTE capability. Despite our department having expertise in focused TTE, the subjective impression was that despite adequate two-dimensional (2D) imaging, experienced operators had difficulty obtaining a CWD envelope and peak jet velocity in patients with AS in one type of machine.
The aim of our study was to compare the CWD peak jet velocity across the aortic valve measured on two different types of semi-portable ultrasound machine in patients with known AS coming for cardiac surgery.
Methods
This study was approved as a low-risk research project by the Human Research and Ethics Committee of our institu-tion, St Vincent's Hospital, Melbourne (Approval No.: LRR 046/13).
Patients with known AS scheduled for cardiac surgery were recruited in the study after written informed consent.
An apical five-chamber view was obtained and the highest peak jet velocity through the aortic valve was recorded on both ultrasound machines using CWD, according to published guidelines 8 .
The time taken to obtain a maximal CWD envelope was recorded in minutes, with five minutes being considered the maximum acceptable time to obtain a satisfactory CWD envelope.
Peak velocity was only measured if the CWD envelope was deemed to be adequate. This required a smooth velocity curve, a dense outer edge and clear maximum velocity as recommended in international guidelines 8 .
Echocardiograms were performed by experienced cardiac anaesthetists with echocardiography training and qualifications. The cardiac anaesthetists were aware the patients had AS, but were blinded as to the severity and any previous cardiology TTE.
The TTEs were performed consecutively with both machines on the same patient, by one anaesthetist (observer 1). Then a second anaesthetist (observer 2), blinded to the measurements of the first, performed consecutive echocardiograms with the two different machines. Machine order was randomised.
All TTEs were performed in awake, spontaneously ventilating patients on the day before or the day of surgery.
The machines and TTE probes being compared were the Vivid I (GE Medical Systems, Milwaukee WI, USA) and the M Turbo (Sonosite, Bothell, WA, USA). We had two M Turbo machines and they were used in the study according to availability.
Velocities measured and time to obtain the spectral envelopes by the two machines were compared using Wilcoxon signed-rank tests. Inter-observer agreement was assessed using Bland-Altman analysis. All analyses were performed using Stata 12.1 (StataCorp, College Station, Texas, USA).
Results
Eighteen patients scheduled for aortic valve replacement, with or without coronary bypass surgery, were recruited to the study. The median (range) age was 77.5 years (46 to 91) and 14 of the 18 (78%) patients were male. All patients had had a formal TTE exam within the previous 30 days.
Adequate 2D imaging and an apical five-chamber view were possible in all patients on both types of machine. Peak aortic jet velocity was able to be measured in all patients (within five minutes by both observers) with the Vivid I, and in 16 of the 18 patients with the M Turbo. In two patients with the M Turbo, we were unable to obtain an adequate CWD envelope. Figure 1 illustrates the continuous-wave peak aortic jet velocity envelope in a patient with both devices.
The peak aortic jet velocities obtained for each patient from the two ultrasound machines are shown in Based on the recommended velocity cut-offs for different degrees of AS, three patients with severe AS based on Vivid I velocities would have been classified as aortic sclerosis based on M Turbo velocities and another seven patients would have had their severity of AS underestimated by at least one degree (e.g. severe to moderate or mild, moderate to mild). The time spent obtaining an adequate CWD spectral envelope was significantly longer with the M Turbo than the Vivid I: median (range) of 5 minutes (1 to 5) versus 3 minutes (1 to 5), P <0.002 for both observers.
Bland-Altman analysis of inter-observer agreement demonstrated a bias of 0.16 m/s and limits of agreement of -0.26 to 0.58 between the two observers' Vivid I velocity measurements, and a bias of 0.24 m/s and limits of agreement of -0.52 to 1.0 between the two observers' M Turbo velocity measurements.
There was no statistically or clinically significant difference between the velocities obtained from the Vivid I ( 
Discussion
The Sonosite M Turbo significantly underestimated the severity of peak aortic jet velocity compared with the Vivid I. In addition, the Sonosite M Turbo required consistently more scanning time in an attempt to obtain an adequate spectral Doppler envelope. This was despite similar and adequate 2D imaging on an apical five-chamber view.
A reliably functioning transducer and ultrasound machine is fundamental in echocardiography. Amongst other factors, this depends on piezoelectric crystals, transducer housing elements, electrical cabling, image processing and machine software. Recent data suggest that up to 40% of machines and transducers used routinely in clinical practice are to some degree dysfunctional 10 . This is despite adequate 2D appearance of greyscale images and has the potential to result in clinical misdiagnosis, particularly with Doppler functions 10 . To date, there is limited data addressing quality control in medical ultrasound and we are unaware of any data looking specifically at portable machines used in the perioperative period. Surprisingly, there are no consistent guidelines for the required frequency and specific testing of devices and many centres rely on routine vendor-specific maintenance, as do we. A recent study suggested than even yearly quality control was inadequate, with transducer and machine problems across a range of vendors and probes 11 . In many centres, the only regular quality control that occurs is vendor-specific maintenance with servicing agreements that were negotiated with initial purchase. Regular routine testing outside of these agreements does reduce the number of dysfunctional probes and machines 11 . Sophisticated proprietary systems can evaluate individual transducer elements in a probe. However, this is expensive and does not reliably exclude issues related to the ultrasound machine, software and signal processing. Nor is it a routine part of most vendor service agreements 10 . We are unaware of a clear reference standard used for comparison and quality assurance of commonly available perioperative ultrasound machines. The specifications in vendor-provided literature of the two machines and probes we compared appear similar. However, patents and proprietary protection of transducer, software and machine technology make it difficult to know exactly how alike the two devices are. CWD involves multiple complex functions including transmitting and receiving elements of the TTE probe, cabling, filtering, demodulation, amplification and signal processing. It is unclear which of the above elements are responsible for the observed underestimating and difficulty obtaining peak jet velocity with CWD in our study. We have shown that the two different types of portable ultrasound machines are not the same in regard to measurement of peak aortic jet velocity. Even in experienced hands with adequate 2D imaging, over half of our patients would have had the diagnosis of moderate-to-severe AS either completely missed or underestimated, based on peak jet velocity. Using the modified Bernoulli equation that all machines use to derive pressure gradients and with the squaring of velocity in this equation (pressure gradient [mmHg] = 4 x velocity [m/s] 2 ), both mean and peak pressure gradients would be grossly underestimated.
Anaesthetists and critical care physicians are increasingly recognising the value of focused echocardiography, with many abbreviated courses now available 12, 13 . We previously found that a group of anaesthesia trainees with no prior echocardiography experience were able to obtain useful quantitative information about AS in less than 20 studies 14 .
The assessment of the aortic valve requires detailed evaluation of structure and function, in addition to spectral Doppler analysis. With experienced echocardiographers being unable to reliably detect probe or machine limitations, the combination of inexperienced, novice echocardiographers working with transducers and machines with limitations could be problematic. Even with experts, 2D imaging is sometimes suboptimal and, in combination with underestimation of aortic valve velocities, clinically significant AS could be missed. Stenotic valvular disease continues to be a risk factor for adverse cardiac events in non-cardiac surgery 5 . Underestimation or failure to diagnose AS preoperatively may falsely reassure all physicians involved in the perioperative period, leading to inappropriate choices of anaesthesia, invasive monitoring, risk stratification, postoperative care location and even proceeding with the surgery.
The quality of imaging in echocardiography varies with each patient. Some patients are very 'echogenic' with favourable imaging. Others require more time and patience to get adequate image quality. This is not entirely predictable with body habitus. This is the nature of echocardiography. We believe it is not unexpected that, for example, an inferior device would adequately perform CWD on 'easy' patients but not on other, more challenging patients. The diagnosis of AS may not be reliably excluded in some patients with a lower-end machine.
Limitations of our study include the lack of blinding of patients, with all anaesthetists being aware that the patient they were scanning had at least some AS. However, even with this knowledge and in experienced hands, a high peak aortic jet velocity was unable to be obtained in more than half of the patients with one machine, despite an adequate continuous-wave envelope, but easily obtainable with the other. It is possible that the Sonosite M Turbo transducer or machine was faulty. However, our department has two such machines, each with two probes, making machine or probe error in both simultaneously less likely. Both of our Sonosite machines are serviced by the company as per the service agreement and the company was contacted regarding our suspicions. There were no known or identifiable problems with the transducer, electrical cabling or machines during the study period. It is also possible that we may have been able to find a better CWD envelope with the Sonosite if we had tried for longer than five minutes. However, a focused TTE is time-limited and just a part of the preoperative evaluation of our patients and our data shows clear differences in the time taken to obtain a satisfactory CWD envelope. It is possible that there are other limitations of Doppler functions with this machine. However, we did not specifically evaluate this and our subjective impression is that 2D imaging was otherwise similar between devices.
Ours is a small preliminary pilot study showing clear differences in CWD function. Should this be verified by additional authors in a larger number of patients, with other M Turbo machines and probes, reviewing the place of this device in the perioperative period when assessing AS would be not unreasonable. Experienced echocardiographers will recognise that the aortic valve is not normal, with calcified and restricted leaflets on 2D appearance, regardless of the CWD envelope. However, we believe anaesthetists who are not experienced echocardiographers may underestimate the severity of aortic valve disease, partly because of the limitations of the equipment they are using.
Conclusion
We have identified significant underestimation of CWD peak aortic jet velocity in patients with known aortic stenosis, with a commonly used cardiac-capable, semi-portable ultrasound machine. We suggest caution when measuring the severity of AS with peak aortic jet velocity with this device and we highlight that all ultrasound machines are not necessarily equivalent.
